Literature DB >> 9620991

Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICP0 null mutant in cells of neural lineage.

R Jordan1, J Pepe, P A Schaffer.   

Abstract

Herpes simplex virus type 1 (HSV-1) ICP0 is required for efficient viral gene expression during lytic infection, especially at low multiplicities. A series of cellular activities that can substitute for ICP0 has been identified, suggesting that when the activity of ICP0 is limiting, these activities can substitute for ICP0 to activate viral gene expression. The cellular activities may be especially important during reactivation of HSV from neuronal latency when viral gene expression is initiated in the absence of prior viral protein synthesis. Consistent with this hypothesis, we have identified an inducible activity in cells of neural lineage (PC12) that can complement the low-multiplicity growth phenotype of an ICP0 null mutant, n212. Pretreatment of PC12 cells with nerve growth factor (NGF) or fibroblast growth factor (FGF) prior to infection produced a 10- to 20-fold increase in the 24-h yield of n212 but only a 2- to 4-fold increase in the yield of wild-type virus relative to mock treatment. Slot blot analysis of nuclear DNA isolated from infected cells treated or mock treated with NGF indicated that NGF treatment does not significantly affect viral entry. The NGF-induced activity in PC12 cells was expressed transiently, with peak complementing activity observed when cells were treated with NGF 12 h prior to infection. Addition of NGF 3 h after infection had little effect on virus yield. The NGF-induced cellular activity was inhibited by pretreatment of PC12 cells with kinase inhibitors that have high specificity for kinases involved in NGF/FGF-dependent signal transduction. RNase protection assays demonstrated that the NGF-inducible PC12 cell activity, like that of ICP0, functions to increase the level of viral mRNA during low-multiplicity infection. These results suggest that activation of viral transcription by ICP0 and transcriptional activation of cellular genes by NGF and FGF utilize common signal transduction pathways in PC12 cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9620991      PMCID: PMC110163     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  82 in total

1.  Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

Authors:  Z Chen; J Hagler; V J Palombella; F Melandri; D Scherer; D Ballard; T Maniatis
Journal:  Genes Dev       Date:  1995-07-01       Impact factor: 11.361

2.  Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor.

Authors:  L Pang; T Sawada; S J Decker; A R Saltiel
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

3.  Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters.

Authors:  P O'Hare; G S Hayward
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

4.  An activity specified by the osteosarcoma line U2OS can substitute functionally for ICP0, a major regulatory protein of herpes simplex virus type 1.

Authors:  F Yao; P A Schaffer
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

5.  Serum supplements and serum-free media: applicability for microcarrier culture of animal cells.

Authors:  J M Clark; C Gebb; M D Hirtenstein
Journal:  Dev Biol Stand       Date:  1981

6.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

Authors:  W R Sacks; C C Greene; D P Aschman; P A Schaffer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

7.  Separation of sequence requirements for HSV-1 Vmw110 multimerisation and interaction with a 135-kDa cellular protein.

Authors:  M Meredith; A Orr; M Elliott; R Everett
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

8.  Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.

Authors:  R D Everett
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

9.  Stimulation of neurite outgrowth in PC12 cells by EGF and KCl depolarization: a Ca(2+)-independent phenomenon.

Authors:  M D Mark; Y Liu; S T Wong; T R Hinds; D R Storm
Journal:  J Cell Biol       Date:  1995-08       Impact factor: 10.539

10.  Selective destruction of nerve growth factor receptor-bearing cells in vitro using a hybrid toxin composed of ricin A chain and a monoclonal antibody against the nerve growth factor receptor.

Authors:  P S DiStefano; J B Schweitzer; M Taniuchi; E M Johnson
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

View more
  8 in total

Review 1.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

2.  Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.

Authors:  Zhilong Yang; Zhangcai Yan; Charles Wood
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 3.  Early expression of herpes simplex virus (HSV) proteins and reactivation of latent infection.

Authors:  J Rajcáni; V Durmanová
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

4.  Herpesvirus quiescence in neuronal cells IV: virus activation induced by pituitary adenylate cyclase-activating polypeptide (PACAP) involves the protein kinase A pathway.

Authors:  R J Danaher; A D Savells-Arb; S A Black ; R J Jacob; C S Miller
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

5.  Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription.

Authors:  L M Schang; J Phillips; P A Schaffer
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

Review 6.  Design and application of oncolytic HSV vectors for glioblastoma therapy.

Authors:  Paola Grandi; Pierpaolo Peruzzi; Bonnie Reinhart; Justus B Cohen; E Antonio Chiocca; Joseph C Glorioso
Journal:  Expert Rev Neurother       Date:  2009-04       Impact factor: 4.618

7.  Zhangfei, a novel regulator of the human nerve growth factor receptor, trkA.

Authors:  Ximena Valderrama; Noreen Rapin; Vikram Misra
Journal:  J Neurovirol       Date:  2008-11-18       Impact factor: 2.643

8.  The kinase inhibitor SFV785 dislocates dengue virus envelope protein from the replication complex and blocks virus assembly.

Authors:  Azlinda Anwar; Takamitsu Hosoya; Kok Mun Leong; Hiroshi Onogi; Yukiko Okuno; Toshiyuki Hiramatsu; Hiroko Koyama; Masaaki Suzuki; Masatoshi Hagiwara; Mariano A Garcia-Blanco
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.